Chartwell Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,741
| Closed | -$1.57M | – | 439 |
|
|
2022
Q2 | $1.57M | Buy |
10,741
+268
| +3% | +$39K | 0.06% | 306 |
|
|
2022
Q1 | $1.24M | Buy |
10,473
+359
| +4% | +$42.6K | 0.04% | 360 |
|
|
2021
Q4 | $1.39M | Buy |
10,114
+2,303
| +29% | +$317K | 0.04% | 354 |
|
|
2021
Q3 | $1.09M | Sell |
7,811
-41
| -0.5% | -$5.7K | 0.03% | 371 |
|
|
2021
Q2 | $762K | Buy |
7,852
+19
| +0.2% | +$1.84K | 0.02% | 392 |
|
|
2021
Q1 | $535K | Sell |
7,833
-230
| -3% | -$15.7K | 0.02% | 394 |
|
|
2020
Q4 | $691K | Buy |
+8,063
| New | +$691K | 0.02% | 386 |
|
|
2020
Q1 | – | Sell |
-20,342
| Closed | -$1.11M | – | 446 |
|
|
2019
Q4 | $1.11M | Buy |
+20,342
| New | +$1.11M | 0.04% | 352 |
|
|
2017
Q4 | – | Sell |
-27,164
| Closed | -$1.02M | – | 440 |
|
|
2017
Q3 | $1.02M | Buy |
+27,164
| New | +$1.02M | 0.03% | 381 |
|